MPW
GILD icon

MASECO Private Wealth’s Gilead Sciences GILD Stock Holding History

MASECO Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.79K Hold
27
– – ﹤0.01% 306
2025
Q4 		$3.34K Buy
+27
New +$3.28K ﹤0.01% 451
2025
Q3 		– Sell
-27
Closed -$3.01K – 366
2025
Q2 		$3.01K Buy
+27
New +$2.87K ﹤0.01% 430

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MASECO Private Wealth's GILD Position: Q1 2026 in Review

MASECO Private Wealth held its Gilead Sciences (GILD) position steady in Q1 2026 at 27 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

MASECO Private Wealth first reported a position in GILD in Q2 2025 and has held it in 3 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MASECO Private Wealth held 27 shares of Gilead Sciences worth $3.79K as of Q1 2026.
  • MASECO Private Wealth left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of MASECO Private Wealth's portfolio in Q1 2026, its #306 holding.
  • MASECO Private Wealth first reported a position in Gilead Sciences in Q2 2025 and has held it in 3 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MASECO Private Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.